Impact of time to progression on first-line therapy on clinical outcomes in advanced gastric cancer treated with apatinib: data from a phase IV study (Ahead-G201).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Guangdong Medical College, Nanjing University of Chinese Medicine, Tongji University, Shanghai East Hospital, Shanxi Provincial Cancer Hospital, Anyang Tumor Hospital, Henan Cancer Hospital, Xinxiang Central Hospital, Central Hospital of Zibo, Tianjin Medical University Cancer Institute and Hospital, Zhejiang Cancer Hospital, Fujian Provincial Cancer Hospital, Union Hospital, Third Affiliated Hospital of Harbin Medical University, Xiangyang Central Hospital, Sun Yat-sen University, Third Affiliated Hospital of Sun Yat-sen University, First Affiliated Hospital of Xiamen University, Changhai Hospital
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2889935366